• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
Menu
GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
  • Our Programs
    • COVID 19
    • Medicines Access
      • Active Drug Safety Monitoring and Management (aDSM) Program
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Maximum Retail Price of Drugs and Medicines
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
    • Medical Device
      • Philippine Essential Medical Device List
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches and Publications
    • Progress Report
    • Drug Price Reference Index Booklet
  • Media Gallery
  • Links
  • AUXILIARY MENU
  • GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
  • Our Programs
    • COVID 19
    • Medicines Access
      • Active Drug Safety Monitoring and Management (aDSM) Program
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Maximum Retail Price of Drugs and Medicines
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
    • Medical Device
      • Philippine Essential Medical Device List
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches and Publications
    • Progress Report
    • Drug Price Reference Index Booklet
  • Media Gallery
  • Links
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer

Rational Use of Antimicrobial Agents and Investigational Drugs for the Management of COVID-19

February 2, 2022 No Comments

The DOH reiterates the rational use of antimicrobials and investigational drugs for COVID-19 management

Read More »

Adjustments in Maximum Retail Price (MRP) Regulation of Certain Medicines that are Covered by Executive Order No. 155 Pursuant to Exemption from Value Added Tax (VAT)

February 10, 2022 No Comments

DOH informs the public of the adjustments in the Maximum Retail Price (MRP) of certain medicines that are covered by EO 155

Read More »

Conduct of the 2022 Antimicrobial Stewardship (AMS) Blended Learning Framework Program for Hospitals through Online Platforms

February 21, 2022 No Comments

The DOH Pharmaceutical Division continues to cascade the National Antimicrobial Stewardship (AMS) training program for hospitals through the blended learning framework

Read More »

Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event as of January 19, 2022

February 28, 2022 No Comments

DOH adds Molnupiravir in the Updated SRP List

Read More »

List of VAT-exempt Drugs and Vaccines Prescribed and Directly Used for COVID-19 Treatment as of 01-22-2022

September 1, 2021 No Comments

The DOH issues list of VAT-exempt drugs and vaccines prescribed and used for COVID-19 management

Read More »